Weixing Qu

1PUBLICATIONS
0CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 10, 2022
NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/<i>β</i>-Catenin Pathway.

Jiancheng Zhou, Jiawei Lai, Yongyi Cheng

Pageof 1

Frequent Collaborators